Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Bartsch

Showing results (321-330 of 332) with videos related to

Pageof 34
Sort By:
Gut|November 2, 2019
Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) ConsortiumMichael Goggins, Kasper Alexander Overbeek, Randall Brand, et al.
Langenbeck'S Archives of Surgery|April 21, 2021
Management of primary and renal hyperparathyroidism: guidelines from the German Association of Endocrine Surgeons (CAEK)T Weber, C Dotzenrath, H Dralle, et al.
Gut|February 9, 2023
IL-17A-producing CD8<sup>+</sup> T cells promote PDAC via induction of inflammatory cancer-associated fibroblastsFelix Simon Ruben Picard, Veronika Lutz, Anna Brichkina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2016
Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert CentersHans Vasen, Isaura Ibrahim, Carmen Guillen Ponce, et al.
Journal of Neuroendocrinology|November 26, 2024
Screening and surveillance practices for Multiple Endocrine Neoplasia type 1-related Neuroendocrine Tumours in European Neuroendocrine Tumor Society Centers of Excellence (ENETS CoE)-An ENETS MEN1 task force questionnaire studyCarolina R C Pieterman, Simona Grozinsky-Glasberg, Dermot O'Toole, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2016
Identification of tissue-specific cell death using methylation patterns of circulating DNARoni Lehmann-Werman, Daniel Neiman, Hai Zemmour, et al.
International Journal of Cancer|June 2, 2004
Prevalence of familial pancreatic cancer in GermanyDetlef K Bartsch, Ralf Kress, Mercedes Sina-Frey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2022
Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)-a randomized phase II trial of the AIO pancreatic cancer groupT Seufferlein, W Uhl, M Kornmann, et al.
Surgery|December 28, 2020
Portal vein resection during pancreaticoduodenectomy for pancreatic neuroendocrine tumors. An international multicenter comparative studyGiuseppe K Fusai, Domenico Tamburrino, Stefano Partelli, et al.
Langenbeck'S Archives of Surgery|December 22, 2024
A retrospective, multicentric, nationwide analysis of the impact of splenectomy on survival of pancreatic cancer patientsMaximilian Kießler, Carsten Jäger, Carmen Mota Reyes, et al.
Pageof 34

Showing results (321-330 of 332) with videos related to

Sort By:
Pageof 34
Gut|November 2, 2019
Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) ConsortiumMichael Goggins, Kasper Alexander Overbeek, Randall Brand, et al.
Langenbeck'S Archives of Surgery|April 21, 2021
Management of primary and renal hyperparathyroidism: guidelines from the German Association of Endocrine Surgeons (CAEK)T Weber, C Dotzenrath, H Dralle, et al.
Gut|February 9, 2023
IL-17A-producing CD8<sup>+</sup> T cells promote PDAC via induction of inflammatory cancer-associated fibroblastsFelix Simon Ruben Picard, Veronika Lutz, Anna Brichkina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2016
Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert CentersHans Vasen, Isaura Ibrahim, Carmen Guillen Ponce, et al.
Journal of Neuroendocrinology|November 26, 2024
Screening and surveillance practices for Multiple Endocrine Neoplasia type 1-related Neuroendocrine Tumours in European Neuroendocrine Tumor Society Centers of Excellence (ENETS CoE)-An ENETS MEN1 task force questionnaire studyCarolina R C Pieterman, Simona Grozinsky-Glasberg, Dermot O'Toole, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2016
Identification of tissue-specific cell death using methylation patterns of circulating DNARoni Lehmann-Werman, Daniel Neiman, Hai Zemmour, et al.
International Journal of Cancer|June 2, 2004
Prevalence of familial pancreatic cancer in GermanyDetlef K Bartsch, Ralf Kress, Mercedes Sina-Frey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2022
Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)-a randomized phase II trial of the AIO pancreatic cancer groupT Seufferlein, W Uhl, M Kornmann, et al.
Surgery|December 28, 2020
Portal vein resection during pancreaticoduodenectomy for pancreatic neuroendocrine tumors. An international multicenter comparative studyGiuseppe K Fusai, Domenico Tamburrino, Stefano Partelli, et al.
Langenbeck'S Archives of Surgery|December 22, 2024
A retrospective, multicentric, nationwide analysis of the impact of splenectomy on survival of pancreatic cancer patientsMaximilian Kießler, Carsten Jäger, Carmen Mota Reyes, et al.
Pageof 34